| Drug Name |
Rabeprazole sodium |
| Drug ID |
BADD_D01899 |
| Description |
Rabeprazole is an antiulcer drug in the class of proton pump inhibitors. It is a prodrug - in the acid environment of the parietal cells it turns into active sulphenamide form. Rabeprazole inhibits the H+, K+ATPase of the coating gastric cells and dose-dependent oppresses basal and stimulated gastric acid secretion. |
| Indications and Usage |
For the treatment of acid-reflux disorders (GERD), peptic ulcer disease, H. pylori eradication, and prevention of gastroinetestinal bleeds with NSAID use. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
A02BC04 |
| DrugBank ID |
DB01129
|
| KEGG ID |
D00724
|
| MeSH ID |
D064750
|
| PubChem ID |
14720269
|
| TTD Drug ID |
D0KL4J
|
| NDC Product Code |
65372-1132; 70518-2590; 45865-802; 71335-0027; 72189-169; 50090-4751; 50090-1424; 71335-1558; 65862-721; 51407-184; 51148-005; 71205-603; 70518-3209; 60760-560; 51148-006; 50090-3145; 68788-7459; 52932-0736; 65862-414; 76420-107; 62856-243; 60760-972; 63187-555; 63187-788; 65977-0033; 50090-3430; 45865-123; 52286-0017; 80425-0134; 55700-767; 53069-0650; 72189-142; 71335-0244; 72888-059; 53104-7568; 71205-292; 55111-055; 80425-0094; 13668-107; 70518-2860; 68180-220; 50090-3182; 42765-013; 71335-0518; 67877-443; 61919-467; 63187-259; 68788-7657; 62175-302; 71335-1100; 53069-0980 |
| Synonyms |
Rabeprazole | 2-((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methylsulfinyl)-1H-benzimidazole | Dexrabeprazole | E 3810 | E3810 | Pariet | Rabeprazole Sodium | Sodium, Rabeprazole | 1H-Benzimidazole, 2-(((4-(3-methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-, Sodium Salt | Aciphex | LY-307640 | LY 307640 | LY307640 |
